Russell Investments Group
AARD

Russell Investments Group’s Aardvark Therapeutics AARD Stock Holding History

Russell Investments Group’s Portfolio AARD Stock Details AARD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.14K Buy
1,239
+770
+164% +$3.6K ﹤0.01% 3993
2026
Q1 		$1.77K Hold
469
– – ﹤0.01% 4008
2025
Q4 		$6.16K Hold
469
– – ﹤0.01% 3877
2025
Q3 		$6.23K Buy
+469
New +$5.29K ﹤0.01% 3862

Other funds holding AARD

DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return

Russell Investments Group's AARD Position: Q2 2026 in Review

Russell Investments Group increased its Aardvark Therapeutics (AARD) stake by 164% in Q2 2026, buying an estimated $3.6K and bringing the position to 1,239 shares worth $7.14K. The position accounts for ﹤0.01% of the portfolio, ranked #3993.

Russell Investments Group first reported a position in AARD in Q3 2025 and has held it in 4 quarters since. 71 funds tracked by Wall St. Rank hold AARD as of Q2 2026.

  • Russell Investments Group held 1,239 shares of Aardvark Therapeutics worth $7.14K as of Q2 2026.
  • Russell Investments Group bought 770 Aardvark Therapeutics shares in Q2 2026, an estimated $3.6K.
  • Aardvark Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3993 holding.
  • Russell Investments Group first reported a position in Aardvark Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 71 funds tracked by Wall St. Rank held Aardvark Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.